Gilder Gagnon Howe & Co’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.47M Buy
129,571
+23,754
+22% +$270K 0.02% 189
2025
Q1
$704K Buy
105,817
+13,271
+14% +$88.3K 0.01% 196
2024
Q4
$1.02M Buy
92,546
+1,791
+2% +$19.8K 0.01% 210
2024
Q3
$1.12M Buy
90,755
+2,178
+2% +$26.8K 0.01% 204
2024
Q2
$1.2M Sell
88,577
-1,206
-1% -$16.3K 0.02% 198
2024
Q1
$1.21M Buy
89,783
+27,535
+44% +$372K 0.02% 206
2023
Q4
$327K Sell
62,248
-11
-0% -$58 ﹤0.01% 233
2023
Q3
$245K Buy
62,259
+11,185
+22% +$44.1K ﹤0.01% 246
2023
Q2
$543K Sell
51,074
-863
-2% -$9.17K 0.01% 245
2023
Q1
$433K Buy
51,937
+29,333
+130% +$244K 0.01% 225
2022
Q4
$209K Sell
22,604
-35,260
-61% -$325K ﹤0.01% 236
2022
Q3
$743K Sell
57,864
-445
-0.8% -$5.71K 0.01% 207
2022
Q2
$770K Sell
58,309
-506,207
-90% -$6.68M 0.01% 209
2022
Q1
$11.9M Sell
564,516
-507,924
-47% -$10.7M 0.11% 128
2021
Q4
$25.7M Sell
1,072,440
-50,915
-5% -$1.22M 0.15% 126
2021
Q3
$28.6M Sell
1,123,355
-122,601
-10% -$3.12M 0.15% 133
2021
Q2
$41.9M Sell
1,245,956
-19,994
-2% -$673K 0.21% 113
2021
Q1
$49.2M Sell
1,265,950
-204,891
-14% -$7.96M 0.27% 101
2020
Q4
$91.1M Sell
1,470,841
-19,312
-1% -$1.2M 0.45% 70
2020
Q3
$49.9M Sell
1,490,153
-79,411
-5% -$2.66M 0.31% 90
2020
Q2
$37.4M Sell
1,569,564
-117,183
-7% -$2.79M 0.29% 90
2020
Q1
$38.6M Sell
1,686,747
-140,143
-8% -$3.21M 0.46% 71
2019
Q4
$51.7M Sell
1,826,890
-49,301
-3% -$1.4M 0.54% 66
2019
Q3
$40.3M Buy
1,876,191
+14,568
+0.8% +$313K 0.46% 68
2019
Q2
$54.3M Buy
+1,861,623
New +$54.3M 0.55% 63